The Super Innovator Search extends VentureBlick’s work to help healthcare innovations scale up and deliver real medical value globally. By leveraging its Discovery platform, VentureBlick seeks to showcase innovators internationally and support the most deserving ones. 

The Super Innovator Search is hosted by VentureBlick with special support from JLK Technology and Kalms Group.

What we are looking for:

• Gamechanging: We seek healthcare startups developing technologies with the potential to create new markets, disrupt existing ones, or fulfil unmet clinical/operational needs. 

• Healthcare-focused: Startups must be in the medtech, biotech, digital health, or life sciences spaces 

• Concrete: Startups must have at least completed initial feasibility studies, or reached the proof-of-concept stage 

• Incorporated: Applicants must be registered companies.

Timeline: 

• Application: 25 June 2024 to 20 August 2024 

• Screening: August 2024 onwards 

• Results: End September 2024

Prizes: 

Up to 3 winners will each receive: 

• Super Innovator status: Up to three rounds of promotional campaigns showcasing each winner to the global healthcare community, valued at US$25,000.  

• Executive advisory: 2 hours of 1-to-1 consultations with Chris Lee, Founder and CEO of VentureBlick, valued at US$5,000. 

• Fundraising support: a targeted 2-month fundraising campaign via VentureBlick's global investor network. 

• Marketing support: A professional 1-minute pitch video, as well as other marketing materials, valued at US$10,000. 

• Discovery Pro: Premium access to VentureBlick’s Discovery platform for a year, valued at US$580. 

• Value-Added Services (Choose 2 out of 3): 

  • Medical validation: A project that assess the winner’s innovation, valued at US$40,000 

  • CDMO support: Design for manufacturing and prototyping credits from JLK Technology, valued at US$20,000 

  • Europe market access support: Reimbursement and market entry support from Kalms Group, valued at US$20,000

Note: The above prizes are offered as is; no equity is expected in exchange.

FAQ: 

What is included in the fundraising support? 

Fundraising support includes a 2-month targeted campaign to introduce winners to VentureBlick’s global network of over 300 investors, as well as other promotional activities such as newsletters and webinars. Although VentureBlick does not take equity in exchange for this support, a standard success fee applies – this will be formalised through a separate contract if the winning startup accepts the prize. 

What is included in the Discovery Pro package? 

The Discovery Pro package provides premium access to VentureBlick’s Discovery platform. This unlocks additional features that can help to enhance the visibility of a platform user, and facilitate connections with key stakeholders such as distributors, corporates, clinicians, and investors. 

What is included in the medical validation report? 

VentureBlick will gather insights from up to 10 clinicians and industry professionals in the VB Advisory Network, from up to 3 different markets. This is a custom evaluation of each winning innovation’s clinical viability and product-market fit, which will be compiled into a report for actionable insights. 

What are the details of the design for manufacturing and prototyping credits? 

The sponsor is JLK Technology, a Singapore-headquartered medical device contract manufacturer. These credits, valued at up to US$20,000, can be used for design and manufacturing consultancy services, or to offset prototype development costs with JLK Technology. Such support helps startups to develop prototypes or conduct small volume production runs. 

This is only applicable for innovators with hardware, and a contract with JLK Technology will be drafted separately to define the scope of work.  

What does Europe Market Access support include? 

The package, valued at up to US$20,000, includes reimbursement and market entry assistance by Kalms Group, a Berlin-based market access consulting company for medical device and pharmaceutical companies to enter Europe. Winners who opt for this prize depending on their stage will be offered either:  

• 64 hours of regulatory support for CE certification, including regulatory gap analysis and QMS-system support, tailored to company needs, or 

• A comprehensive market analysis and go-to-market strategy for Germany, covering case numbers, clinical guidelines, key opinion leaders, reimbursement, competition, clinical evidence, and an action plan, or

• One half-day workshop addressing the above points with focus on Germany / Europe. This will help the company understand what they need to do.

A contract with Kalms Group will be drafted separately to define the scope of work.

About the organiser 

VentureBlick is the one-stop go global solution for healthcare innovation, making cross-border cross-sector connections to take local innovations worldwide. We unite innovators, clinicians, investors, and ecosystem partners on a global scale for better visibility and efficiency. Headquartered in Singapore, we also operate in other markets including Korea, Germany, India, and China.

About the sponsors 

JLK Technology is a leader in smart manufacturing with over 30 years of expertise in custom automation and precision machining. Its partners range from startups to Fortune 100 companies in the medtech, life sciences, consumer electronics, and automotive industries. Based in Singapore with facilities across Asia, JLK offers comprehensive services including automation, production, and software development. 

The Kalms Group are a specialist in regulatory compliance, market access and fulfilment services for healthcare companies. The teams of Kalms Consulting and Kalms Operations offer expertise to healthcare companies looking to expand in Europe and N. America, providing strategic support for successful market entry and reimbursement processes as well as all relevant services that are needed for commercialisation.